| Age (years, (SD)) | 78 (5.3) |
| Sex (% women, (n)) | 41% (9) |
| BMI (kg/m2, (SD)) | 26 (4.0) |
| SBP/DBP¥ (mmHg, (SD)) | 151 / 83 (22 / 13) |
| MoCA (score, (SD)) | 26* (2) |
| Self-reported comorbidities (%, (n)) |
| Myocardial infarction | 18% (4) |
| Arterial fibrillation | 5% (1) |
| Hypertension | 41% (9) |
| Hypercholesterolemia | 18% (4) |
| Diabetes | 0% (0) |
| Arthrosis | 27% (6) |
| Medication use (%, (n)) |
| Antihypertensive drugs | 50% (11) |
| ARB | 18% (4) |
| ACE inhibitor | 23% (5) |
| Diuretic | 18% (4) |
| Beta blocker | 23% (5) |
| Calcium channel blocker | 5% (1) |
| Statins | 23% (5) |
| Antithrombotic agents | 23% (5) |
| Activity pattern by activPAL† |
| Sedentary time (hours/day, (SD)) | 10.3 (1.6) |
| Sleep time (hours/day, (SD)) | 8.2 (0.9) |
